Epidemiology, risk factors and outcomes of multi-drug-resistant bloodstream infections in haematopoietic stem cell transplant recipients: importance of previous gut …

AM Ferreira, F Moreira, T Guimaraes, F Spadão… - Journal of Hospital …, 2018 - Elsevier
Background Bloodstream infections (BSI) are a major complication in the early phase of a
haematopoietic stem cell transplant (HSCT). Aim To describe the incidence and risk factors …

[HTML][HTML] Risk factors for mortality in hematopoietic stem cell transplantation recipients with bloodstream infection: points to be addressed by future guidelines

P Puerta-Alcalde, M Chumbita, P Charry… - … and Cellular Therapy, 2021 - Elsevier
In recent years, important epidemiologic changes have been described in hematopoietic
stem cell transplantation (HSCT) recipients with bloodstream infection (BSI), with increases …

Clinical characteristics, microbiology, and risk factors for mortality of pre-engraftment and post-engraftment bloodstream infection in hematopoietic stem cell …

W Chen, Y Zhao, Y Luo, J Yu, H Fu, X Lai… - Infection and Drug …, 2022 - Taylor & Francis
Background Bloodstream infection (BSI) is a common and serious complication that may
lead to high mortality during the different phases after hematopoietic stem cell transplant …

Bacterial bloodstream infections after allogeneic hematopoietic stem cell transplantation: etiology, risk factors and outcome in a single-center study

J Gill, A Busca, N Cinatti, R Passera, CM Dellacasa… - Microorganisms, 2023 - mdpi.com
Background—Allogeneic hematopoietic stem cell transplant (allo-HSCT) recipients are
subject to major risks for bacterial bloodstream infections (BSIs), including emergent …

Bloodstream infections in allogeneic haematopoietic cell recipients from the Swiss Transplant Cohort Study: trends of causative pathogens and resistance rates

M Sava, V Bättig, S Gerull, JR Passweg… - Bone Marrow …, 2023 - nature.com
Bloodstream infection (BSI) is the most common infectious complication after allogeneic
haematopoietic cell transplantation (HCT) affecting 20-60% of patients in the pre-and early …

Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients

M Mikulska, V Del Bono, P Bruzzi, AM Raiola… - Infection, 2012 - Springer
Abstract Purpose Bloodstream infections (BSIs) are frequent after allogeneic haematopoietic
stem cell transplantation (HSCT). The aim of this study was to identify predictors of mortality …

Incidence, risk factors, and outcome of bloodstream infections during the pre‐engraftment phase in 521 allogeneic hematopoietic stem cell transplantations

O Blennow, P Ljungman, E Sparrelid… - Transplant Infectious …, 2014 - Wiley Online Library
Background Bloodstream infection (BSI) after allogeneic hematopoietic stem cell
transplantation (HSCT) is a well‐known complication during the pre‐engraftment phase …

[HTML][HTML] Gastrointestinal graft-versus-host disease is a risk factor for postengraftment bloodstream infection in allogeneic hematopoietic stem cell transplant recipients

Y Mori, G Yoshimoto, R Nishida, T Sugio… - Biology of Blood and …, 2018 - Elsevier
Bloodstream infection (BSI) is a well-known cause of morbidity and mortality in allogeneic
hematopoietic stem cell transplant (allo-HSCT) recipients. Here, we conducted a …

[HTML][HTML] Secular trends of bloodstream infections during neutropenia in 15 181 haematopoietic stem cell transplants: 13-year results from a European multicentre …

M Weisser, C Theilacker, ST Sutter, R Babikir… - Clinical Microbiology …, 2017 - Elsevier
Objectives Antibacterial resistance is emerging in patients undergoing haematopoietic stem
cell transplantation (HSCT), and most data on the epidemiology of bloodstream infections …

Risk factors for pre‐and post‐engraftment bloodstream infections after allogeneic hematopoietic stem cell transplantation

M Kikuchi, Y Akahoshi, H Nakano… - Transplant Infectious …, 2015 - Wiley Online Library
Background Bloodstream infections (BSI) are frequently observed after allogeneic
hematopoietic stem cell transplant (HSCT), and could cause morbidity and mortality …